The Hellenic BioCluster (HBio) is the first biosciences cluster in Greece bringing together the innovation leaders of Greece in the sectors of Pharmaceuticals, Biotechnology, Diagnostics, Medical Devices and Specialised Services.
Established in 2006 by an initial group of 8 companies and the PRAXI Network, the technology transfer arm of the Foundation for Research & Technology- Hellas (FORTH), the Hellenic BioCluster has grown to date to over 30 innovation-intensive companies with an international outlook.
HBio aims to boost the development of the Life Sciences industry in Greece, to promote the Greek Life Sciences sector in the international scene and to facilitate business and research collaborations between local and international companies and research groups.
HBio is a frequent interlocutor of the Hellenic government on matters of policy design in the areas of innovation support and life sciences strategy. It is also an active member of the Σynergies initiative which seeks to promote intra-sectoral collaborations in the high tech space.
As part of its support of the next generations, HBio is a sponsor of conferences and student competitions related to the life sciences, innovation and youth entrepreneurship.
Good health is at the centre of happy, productive lives. We believe that good science and a collaborative attitude are instrumental to advancing the state of the art and providing better health for all. We are working to support companies and research organisations in their international outlook and in their contribution to the global “health for all” effort.
OUR STRATEGIC GOALS
To promote the contribution and role of the Greek Healthcare industry on the global scene.
To foster collaborations between HBio members and international players.
To support members in their export orientation and international business development.
To foster the exchange of knowledge between HBio members and the international healthcare community.
To encourage and support entrepreneurship and innovation in the healthcare space.